Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.

scientific article

Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3324/HAEMATOL.2015.135699
P8608Fatcat IDrelease_eplmm3lvjzc45ckefwgd7v32ay
P932PMC publication ID4938329
P698PubMed publication ID26565001

P50authorDietger NiederwieserQ88402151
Myriam LabopinQ89534568
Emmanuelle PolgeQ89534576
Arnon NaglerQ89534579
Fabio CiceriQ90995474
Sebastian GiebelQ92489652
Arnold GanserQ99412936
Rainer SchwerdtfegerQ114426804
Stephane VigourouxQ114428271
Bipin N SavaniQ53683697
Noel Jean MilpiedQ55743774
Boris AfanasyevQ60608189
Mohamad MohtyQ86836425
Didier BlaiseQ88013295
P2093author name stringMichael Hallek
Jan J Cornelissen
Frédéric Baron
Christoph Schmid
Jordi Esteve
Renate Arnold
Norbert C Gorin
P2860cites workBone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsQ24195048
Defining the intensity of conditioning regimens: working definitionsQ24630836
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionQ34033852
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantationQ34582448
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosisQ34620456
Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent eraQ34749365
Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancyQ34749391
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantationQ34996663
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trialQ34998580
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.Q35288778
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationQ35571053
Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.Q35800814
Peripheral-blood stem cells versus bone marrow from unrelated donorsQ37276359
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseQ37632798
Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantationQ38284507
Reduced-intensity conditioned allogeneic SCT in adults with AML.Q38366632
1994 Consensus Conference on Acute GVHD GradingQ39513397
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitutionQ43001701
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the EuropeaQ43992557
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants.Q44275281
Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignanciesQ44447834
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis froQ45216935
Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.Q52905842
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.Q54684597
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialQ74389035
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized studyQ78385763
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia WorkingQ84258632
P433issue2
P921main subjectacute leukemiaQ976388
leukemiaQ29496
P304page(s)256-262
P577publication date2015-11-12
P1433published inHaematologicaQ5638209
P1476titlePeripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
P478volume101

Reverse relations

cites work (P2860)
Q52718440AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation.
Q90065178Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF
Q37618811Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Q94562861Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia
Q94496786Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT
Q39414681Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy
Q58713268Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT
Q48103108Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia.
Q39031745Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy
Q92757989Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?
Q90325829Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients
Q52584529Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia.
Q38863489Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.
Q30240238Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens
Q57158669Trends in peripheral stem/progenitor cell manipulation and clinical application

Search more.